Methodology

All entries for: Keros Therapeutics Inc.

August 18, 2025

Keros Therapeutics Inc.

Orphan Drug Designation

FDA orphan drug designation: treatment of Duchenne muscular dystrophy

Disease Area: Rare Diseases
Source
Source
Scroll to Top